The use of foetal human brain tissue as brain implants: Phenotype manipulation by genetic manipulation and biochemical induction

Keio Journal of Medicine

Volumn 51, Issue 3, 2002, Pages 148-153

  Bradford, Henry F ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cell graft transplantation; Dopamine; Parkinson's disease; Phenotype manipulation; Stem cells

Indexed keywords

TYROSINE 3 MONOOXYGENASE;

ARTICLE; BRAIN TRANSPLANTATION; FETAL TISSUE TRANSPLANTATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; MESENCEPHALON; METHODOLOGY; PARKINSON DISEASE; PHENOTYPE; TRANSPLANTATION;

BRAIN TISSUE TRANSPLANTATION; FETAL TISSUE TRANSPLANTATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MESENCEPHALON; PARKINSON DISEASE; PHENOTYPE; TRANSFECTION; TYROSINE 3-MONOOXYGENASE;

EID: 0036729074     PISSN: 00229717     EISSN: None     Source Type: Journal    
DOI: 10.2302/kjm.51.148     Document Type: Article

References (12)

1. Hurley M, Gerard D, Jauniaux ERM, Stern GM, Uchida K, Bradford HF: Cultured human foetal cerebral cortex, transfected with tyrosine hydroxylase cDNA as a source of neural transplant material. J Neural Transm 2000; 108: 781-792
2. Zhou J, Bradford HF, Stern GM: Induction of dopaminergic neurotransmitter phenotype in rat embryonic cerebral cortex by the synergistic action of neurotrophins and dopamine. Eur J Neurosci 1996; 8: 2328-2339
3. Zhou J, Bradford HF: Nerve growth factors and control of neurotransmitter phenotype plasticity in the mammalian nervous system. Prog Neurobiol 1997; 53: 27-43
4. Zhou J, Pleigo-Rivero B, Bradford HF, Stern GM, Jauniaux ERM: Induction of tyrosine hydroxylase gene expression in human foetal cerebral cortex. Neurosci Lett 1998; 252: 215-217
5. Pliego-Rivero B, McCormack WJ, Jauniaux E, Stern GM, Bradford HF: Forskolin-induced expression of tyrosine hydroxylase in human foetal cerebral cortex. Dev Brain Res 1999; 114: 201-206
6. Zhou J, Bradford HF, Stern GM: The stimulatory effect of brain-derived neurotrophic factor on dopaminergic phenotype expression of embryonic cortical neurons in vitro. Dev Brain Res 1994; 81: 318-324
7. Riaz SS, Jauniaux REM, Stern GM, Bradford HF: The controlled conversion of human progenitor cells derived from foetal ventral mesencephalon into dopaminergic neurons in vitro. Dev Brain Res 2001; 136: 127-134
8. Spencer DD, Robbins RJ, Naftolin F, Marek KL, Vollmer T, Leranth C, Roth RH, Price LH, Gjedde A, Bunney BS, et al: Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med 1992; 327: 1541-1548
9. Ahlskog JE: Cerebral transplantation for Parkinson's disease: current progress and future prospects. Mayo Clin Proc 1993; 68: 578-591
10. Olanow CW, Kordower JH, Freeman TB: Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci 1996; 19: 102-109
11. Walters AM, Clarke DJ, Bradford HF, Stern GM: The properties of cultured fetal human and rat brain tissue and its use as grafts for the relief of the Parkinsonian syndrome. Neurochem Res 1992; 17: 893-900
12. Martinez-Serrano A, Bjorkland A: Immortalized neural progenitor cells for CNS gene transfer and repair. Trends Neurosci 1997; 20: 530-538